[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

1 Recruiting

2 Completed trials

2 Sponsors

16 Countries

Phase III

Phase II

Phase I (Other)

Phase III: 1 Phase II: 2 Phase I (Other): 1

Sponsors using this IMP

4 total

PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Pending

2025-523425-17-00 Phase II 16 countries Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Phase III 15 countries Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
A study in healthy men to test how BI 764198 is processed in the body Ended

2022-502327-22-00 Phase I (Other) 1 country Boehringer Ingelheim International GmbH
A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis Ended

2024-511706-23-00 Phase II 5 countries Boehringer Ingelheim International GmbH

Showing 1–4 of 4 trials